Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.8M Hold
75,000
– – ﹤0.01% 2388
2026
Q2
$4M Buy
+75,000
New +$4.06M ﹤0.01% 1958
2025
Q4
– Sell
-28,400
Closed -$1.38M – 5836
2025
Q3
$1.38M Buy
+28,400
New +$1.45M ﹤0.01% 3163

Other funds holding AMRZ

Barclays's AMRZ Position: Q3 2026 in Review

Barclays reduced its Amrize (AMRZ) stake by 7.1% in Q3 2026, selling an estimated $11.7M and leaving 3,347,588 shares worth $125M. The position accounts for 0.03% of the portfolio, ranked #428.

Barclays first reported a position in AMRZ in Q2 2025 and has held it in 6 quarters since. The position peaked at $250M in Q4 2025. 429 funds tracked by Wall St. Rank hold AMRZ as of Q3 2026.

  • Barclays held 3,347,588 shares of Amrize worth $125M as of Q3 2026.
  • Barclays sold 257,210 Amrize shares in Q3 2026, an estimated $11.7M.
  • Amrize made up 0.03% of Barclays's portfolio in Q3 2026, its #428 holding.
  • Barclays first reported a position in Amrize in Q2 2025 and has held it in 6 quarters since.
  • Barclays's Amrize position peaked at $250M in Q4 2025.
  • 429 funds tracked by Wall St. Rank held Amrize as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.